Dear Sirs, Council for Evidence-based Psychiatry (CEP),
I think that your concerns regarding psychiatric drugs, explained with great detail and cogent arguments through your website, are legitimate and well-founded.(1) I also found the response by Nutt and colleagues shameful and insulting, I’ll like to express here my firm intention to answer that letter in The Lancet.
1. Re: Putting GlaxoSmithKline to the test over paroxetinehttp://www.bmj.com/content/347/bmj.f6754/rr/816737
Jorge H. Ramírez
Assistant Professor of Pharmacology
Universidad del Valle, Cali, Colombia.
Response originally posted on CEP website: http://cepuk.org/2014/08/19/full-text-cep-members-letter-lancet-psychiatry-response-article-nutt-et-al/#comment-6651
Original article by Nutt and colleagues: http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(14)70232-9/fulltext?_eventId=login